Alex Matter, MD

Director of the Experimental Therapeutics Centre, Singapore

Dr Matter is director of the A*STAR Experimental Therapeutics Centre, Singapore, previously serving as Global Head for Oncology Research at Novartis. He has contributed to the successful marketing of several anti-cancer drugs including, most recently, Gleevec/Glivec and has published more than 100 scientific articles plus several book chapters in the fields of oncology and hematology. He is the recipient of the 13th Warren-Alpert prize in 2000 and the AACR-Bruce F. Cain Memorial Award.

Back to overview